QIAN WANG: Open Payments
NPI 1619572013 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 46 payments from 10 companies in 2025. Trend: 2023 $310 · 2024 $828 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $399 |
| Janssen Biotech, Inc. | 9 | $267 |
| Ardelyx, Inc. | 3 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $126 |
| Gilead Sciences, Inc. | 1 | $124 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Amgen Inc. | 1 | $19 |
Products named: TREMFYA, SKYRIZI, RINVOQ, IBSRELA, ENTYVIO, VOQUEZNA, XIFAXAN, OMVOH.
Industry payments across NY — which companies pay providers there.
